Un nouveau laboratoire de biologie médicale a ouvert ses portes à Chasseneuil-du-Poitou, en mars 2025. Il propose un large éventail d’analyses : prélèvements sanguins, microbiologiques ...

C’est notamment vrai pour les rivières du Kochersberg, particulièrement vulnérables, et qui font aujourd’hui fonction de laboratoire à ciel ouvert de la lutte contre les contaminations de ...

Des thermomètres numériques de poche aux enregistreurs de données sophistiqués pour les applications de sécurité alimentaire, en passant par les thermomètres de laboratoire de haute ...

The vast majority of Medicare's top-selling brand-name oncology drugs in 2022 provided high added therapeutic benefit. Ten drugs were classified as low or no added therapeutic benefit compared ...

Panelists discuss how the five-year prognosis for advanced non-small cell lung cancer (NSCLC) has improved with PD-1 inhibitors, showing promising overall survival (OS) and progression-free survival ...

How does histology, staging and ECOG performance status play into treatment considerations at your practice today, and how do these factors compare to the baseline characteristics of this study? What ...

Nala Care: Natural and effective personal care products. Omy Laboratoires: Quebec-based brand harnessing AI technology to develop innovative and custom skincare solutions. Province Apothecary: A ...

and cemiplimab (Libtayo), an anti–PD-1 agent, in patients with advanced melanoma. 1 The first-in-human, phase 1, open-label, dose-escalation and cohort expansion trial sought to evaluate the safety ...

Therefore, Senhwa will actively pursue licensing possibilities while carefully evaluating CX-4945's potential as a monotherapy or in combination with the second-line immunotherapy Libtayo. The company ...

Therefore, Senhwa will actively pursue licensing possibilities while carefully evaluating CX-4945's potential as a monotherapy or in combination with the second-line immunotherapy Libtayo.

Regeneron's main product is Duxipent, an autoimmune disease drug. It sells Libtayo, a cancer drug that recently got approved for a new medical indication. Both drugs are sold through a partnership ...